HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dikaia Xenaki Selected Research

Dikaia Xenaki Research Topics

Disease

4Respiratory Tract Diseases (Respiratory Tract Disease)
10/2021 - 01/2020
3Fibrosis (Cirrhosis)
01/2021 - 01/2020
2Lung Diseases (Lung Disease)
10/2021 - 01/2020
2Inflammation (Inflammations)
01/2021 - 01/2017
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2017
2Asthma (Bronchial Asthma)
01/2020 - 01/2018
1Pneumonia (Pneumonitis)
10/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020
1Respiratory Hypersensitivity
01/2020
1Iron Overload
01/2020
1Idiopathic Pulmonary Fibrosis
01/2020
1Airway Remodeling
01/2018

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2021
2CytokinesIBA
01/2021 - 01/2020
2IronIBA
01/2020 - 01/2020
2Transferrin Receptors (Transferrin Receptor)IBA
01/2020 - 01/2020
1Therapeutic UsesIBA
10/2021
1OligodeoxyribonucleotidesIBA
10/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1Histones (Histone)IBA
01/2021
1CollagenIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1TenascinIBA
01/2021
1indium-bleomycinIBA
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1Chelating AgentsIBA
01/2020
1Deferoxamine (Desferal)FDA LinkGeneric
01/2020
1MetalsIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Connective Tissue Growth FactorIBA
01/2018
1RoflumilastIBA
01/2017
1Phosphodiesterase 4 InhibitorsIBA
01/2017
1SteroidsIBA
01/2017

Therapy/Procedure

1Therapeutics
02/2021